NCT01150500

RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries

RESOLUTE JAPAN SVS: The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 65 (actual)
• Sponsor: Medtronic Vascular · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study is To verify the safety and efficacy of the MDT-4107 Drug-Eluting Coronary Stent in the treatment of de novo lesions in native coronary arteries with a reference vessel diameter (RVD) that allows the use of 2.25mm diameter stents.

Detailed description

The objective of the study is to verify the safety and efficacy of the MDT-4107 Drug-Eluting Coronary Stent in the treatment of de novo lesions in native coronary arteries with a reference vessel diameter (RVD) that allows the use of 2.25mm diameter stents.

Conditions

• Arterial Occlusive Diseases
• Myocardial Ischemia
• Cardiovascular Diseases
• Coronary Artery Disease

Interventions

Type	Name	Description
DEVICE	MDT-4107 Zotarolimus-Eluting Coronary Stent

Timeline

• Start date: 2010-06-01
• Primary completion: 2011-10-01
• Completion: 2016-06-01
• First posted: 2010-06-25
• Last updated: 2017-03-14
• Results posted: 2012-11-30

Locations

1 site across 1 country: Japan